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Renal biopsy is an invasive specialized test aimed at obtaining renal tissue for 
histologic diagnosis of a variety of kidney diseases. Common indications for renal 
biopsy in practice include adult nephrotic syndrome, steroid resistant or clini-
cally atypical nephrotic syndrome in children, glomerulonephritis, acute kidney 
injury (AKI) of unknown aetiology, systemic diseases with renal involvement, 
and persistent proteinuria or haematuria with reduced renal function. Over the 
years there has been continuous refinement of renal biopsy techniques. It is now 
mostly performed percutaneously using imaging guidance and more sophisticated 
spring-loaded needles of varying sizes. Other non-percutaneous techniques such 
as transjugular, laparoscopic and open renal biopsy are also being performed 
especially in patients with contraindications to the percutaneous approach. 
Percutaneous ultrasound guided approach is standard care for biopsy of non-focal 
lesions. The CT-guided method can be used in obese patients and other patients 
who are unable to lay prone, patients with complex anatomy, and when the kidneys 
are not sufficiently visualised by ultrasound scan. The transjugular technique is 
most popular for combined liver and kidney biopsy. The major advantages of the 
laparoscopic and open biopsy techniques are the opportunity for direct visualiza-
tion of the kidney and good intra-operative haemostasis.
Keywords: renal biopsy, transjugular biopsy, percutaneous renal biopsy,  
open renal biopsy
1. Introduction
Renal biopsy is an invasive specialized test aimed at obtaining renal tissue for 
histologic diagnosis of a variety of kidney diseases. Kidney biopsy is generally 
indicated when, (1) the cause of kidney disease cannot be sufficiently determined 
or predicted clinically or by less invasive diagnostic procedures, (2) clinical features 
suggest parenchymal disease that can be diagnosed by pathologic evaluation and (3) 
the differential diagnosis includes diseases that have different treatments, prognosis 
or both [1].
Common indications for renal biopsy in practice include adult nephrotic 
syndrome, steroid resistant or clinically atypical nephrotic syndrome in children, 
glomerulonephritis, acute kidney injury (AKI) of unknown aetiology, systemic 
diseases with renal involvement, and persistent proteinuria or haematuria with 
reduced renal function. Sometimes diagnosis of kidney disease is clinically appar-
ent, however a biopsy may be required for confirming diagnosis, assessing disease 
activity, chronicity and severity, e.g. in systemic lupus erythematosus [2].
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Renal biopsy may be associated with complications such as bleeding, pain, infections, 
injury to contiguous structures, and very rarely loss of a kidney or death of the patient. 
The safety and usefulness of renal biopsy in the diagnosis, monitoring and treatment of 
renal parenchymal diseases largely depends upon correct selection and adequate prepa-
ration of the patient, the skillfulness of the operator, and the technique used.
Over the years there has been a continuous refinement of renal biopsy tech-
niques. It is mostly performed percutaneously using imaging guidance and 
more sophisticated soft-tissue needles (Figure 1a-c) of varying sizes. Other 
Figure 1. 
Soft tissue biopsy needles: (a) Tru-Cut, (b) semi-automated biopsy needle, and (c) automated biopsy needle.
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non-percutaneous techniques such as transjugular renal biopsy, laparoscopic and 
open renal biopsy are also being performed especially in patients with contraindica-
tions to the percutaneous approach.
2. Methods of renal biopsy
Iversen and Brun introduced percutaneous renal biopsy (PRB) of native kidneys 
in 1951, when they performed the procedure in a sitting patient using an aspira-
tion needle after localizing the kidney with intravenous pyelography [3]. Although 
this innovation revolutionized the nephrology practice at the time, the tissue yield 
was inadequate in up 47% of the biopsies they performed over time [3]. Since then 
other percutaneous methods have been introduced and practiced with better tissue 
yields of up to 95–99% in some series [4–6]. Despite these encouraging figures, 
the tissue obtained is sometimes not diagnostically useful. This can be due to poor 
patient selection, wrong or poor technique, and inappropriate tissue handling, i.e., 
division of tissue for the different histopathologic examinations, and storage. The 
nephrologist should be adequately knowledgeable of indications, contraindications 
and complications of renal biopsy, and the several techniques available. This will 
significantly help to improve the usefulness of this procedure in terms of individual 
patient care and outcome.
Renal biopsy may be performed by one of the following approaches: per-
cutaneous blind, blind after localisation with ultrasound scan, percutaneous 
real-time ultrasound guided, percutaneous CT guided, transjugular renal biopsy, 
laparoscopic renal biopsy, and open renal biopsy. The choice of technique among 
physicians often depends on skillfulness, availability of equipment and compelling 
indications in the patient. The techniques are briefly described below.
2.1 Percutaneous blind
This technique is now obsolete in advanced countries, but still being practiced 
in some centres in low and low-middle income countries. The patient is placed 
in the prone position with a pillow or towel under the abdomen; the lower pole 
of the kidney to be biopsied is localised using the anatomic landmark (the tip 
of the twelfth rib posteriorly). Thereafter the skin is prepped, draped, and local 
anaesthetic is used to infiltrate the skin down to the kidneys. Either the manual 
(Tru-Cut) or spring-loaded biopsy needle is inserted through a nick made on the 
anaesthetized skin, and advanced towards the renal capsule while patient breaths 
gently. When the needle just pierces the renal capsule (signified by a give and 
swinging of the biopsy needle with respiratory excursions), the patient is instructed 
to hold the breath, and the biopsy cut is taken. Patient is observed usually for at 
least 6–8 hours, but may require longer admission depending on the presence of 
complications. This technique can be cumbersome and potentially associated with 
complications; tissue yield is often not optimal and several passes may be required 
to obtain adequate tissue.
2.2 Percutaneous ultrasound guided
Percutaneous ultrasound guided biopsy is the standard of care [7]. This 
technique can be performed blind after localizing the kidney with an ultra-
sound probe, or performed with real-time ultrasound guidance. The patient 
is placed in a prone position with a towel or pillow beneath the abdomen to 
ensure proper positioning and to stabilize the kidney. The lower pole of the 
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kidney is localized using the ultrasound probe placed around the renal angle 
posteriorly (Figure 2). The area of skin overlying the lower pole can be marked 
and the probe removed (blind) or the probe is used to guide the biopsy needle 
throughout the procedure (real-time). From this point on the procedure is 
similar to the blind technique.
The use of ultrasound guidance is now universally available in most countries 
globally, except for some centres in low and low-middle income countries where the 
ultrasound machine may not be available in the centre or to the nephrologist. The 
implication of this is that nephrologists in such centres may not have the skill required 
and this contributes to declining practice of renal biopsy in many of such centres.
2.3 CT guided percutaneous
CT guided PRB may be the primary imaging technique or is indicated in obese 
patients, patients with complex kidney anatomy (e.g. vascular anomaly, horse-shoe 
kidney), focal lesions, those in whom kidneys are not well visualized on ultrasound 
and in patients who have difficulty lying prone [7, 8]. Interventional nephrologists 
or radiologists perform this procedure in the CT suite. Patients are usually fasted 
for 8 hours to allow for administration of conscious sedation. An intravenous line 
is secured for fluid administration and monitoring equipment for vital signs and 
pulse oximetry are attached to patient [9]. Patient with difficulties lying prone are 
placed in the ipsilateral side-up position, however the location of a focal lesion also 
influences the position chosen, e.g. lesions along the lateral edge of the kidney may 
be difficult to access with an ipsilateral side-up approach [9].
After adequately positioning the patient, a localizing grid is placed and pre-
liminary CT images at 5 mm axial slices covering the entire length of the kidney 
is obtained. Thereafter, the shortest and safe route is chosen, the skin overlying 
kidney is prepped, draped and anaesthetized with 1% lidocaine. A coaxial needle 
is advanced to the kidney with CT guidance and core biopsy samples or fine needle 
aspirates are collected [9]. Once all samples are collected the needle is removed and 
post-care is given, including a post-procedure imaging to exclude haemorrhage.
2.4 Transjugular renal biopsy
Mal who intended to carry out a liver biopsy but accidentally also obtained 
renal tissue first performed this procedure in 1989 [10]. Thereafter he further 
explored the feasibility of the procedure and it has since been practiced with 
success. Transjugular renal biopsy (TJRB) is performed in a radiology suite by 
either an interventional nephrologist or radiologist with fluoroscopy guidance. 
Figure 2. 
Percutaneous ultrasound guided renal biopsy.
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The aspiration needle or core biopsy approach may be used and the main differ-
ence between the two approaches is the biopsy instrument.
The right internal jugular vein is often preferred due to its straighter course to 
the inferior vena cava. Following injection of local anaesthetic to skin and subcu-
taneous area, the vein is punctured with an 18-guage needle just above the thyroid 
cartilage medial to the sternal head of the sternocleidomastoid [11]. A guide wire 
is inserted and then a venous sheath is introduced over it. Next the catheter is 
advanced under fluoroscopic guidance through the IVC into the right renal vein. 



























































































Skill requirement + ++ +++ +++ ++
G. A No No Yes Yes No
Cost + ++ +++ +++ ++
*Patient’s refusal or uncooperative patients are universal contraindication to all approaches.
Table 1. 
Comparing the biopsy techniques.
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lock syringe, is advanced down the catheter to obtain the tissue core (core biopsy 
technique) [11]. More than one pass is usually possible to improve tissue yield.
2.5 Laparoscopic and open biopsy
Laparoscopic biopsy is usually performed by a urologist mostly via the retro-
peritoneal approach but can be approached transperitoneally. The patient receives 
general anaesthesia, is placed in full right or left flank position, prepped and 
draped. Using a two-port technique, firstly the retroperitoneum is entered in the 
posterior axillary line, halfway between the ribs and iliac crest [12]. The lower pole 
of the kidney is then localized by blunt dissection with the laparoscopic lens to 
create a space posterior to the kidney. Next a 5 mm trochar is inserted under direct 
vision in the anterior axillary line at the level of the iliac crest to identify the kidney; 
the biopsy is taken using a laparoscopic biopsy forceps [12]. Multiple biopsies can 
be taken and thereafter haemostasis is secured. In uncertain cases, intraoperative 
ultrasonography can be performed via a laparoscopic probe, to confirm renal tissue 
before biopsy [12, 13].
Open biopsies can be performed in patients with contraindication to PRB, or 
during open abdominal surgeries for other renal indications, e.g. taking a biopsy 
during a partial nephrectomy. Some patients refuse open biopsies on religious 
grounds (Jehovah’s witness refusing blood transfusion) [12], so the laparoscopic 
technique becomes the preferred option (Table 1).
3. Specimen handling and processing
The manner in which the biopsy core collected is handled and processed 
contributes to the diagnostic and prognostic usefulness. The tissue core should be 
gently removed from the biopsy needle using an 18G needle, or washed from the 
needle onto a Petri dish, using a slow jet of normal saline. A magnifying lens or a 
dissecting microscope should be used immediately to confirm it is kidney tissue, 
and whether it is cortex or medulla. The renal cortex appears pale pink to tan with 
reddish blushes depicting the glomeruli, while the medulla usually contains straight 
red striations representing vasa recta [14].
The biopsy operator must be knowledgeable of effective ways of dividing the 
renal core obtained when needed, and the right fixative to use. This ensures that 
adequate samples are delivered to the pathologist, for the different processing and 
fixation methods required for light microscopy (LM), immunohistochemistry 
(IHC) and electron microscopy (EM). At least three cores are required, one each 
for LM, IHC and EM. The need for dividing tissue core arises if the number of cores 
obtained is inadequate, e.g. if only one core is obtained, 1 mm cuts are made from 
both ends for EM, while the remainder is cut in two, the larger of which is used for 
LM while the other for IHC [14]. Specimen should be placed quickly in appropriate 
fixatives and accompanied with adequate clinical information to guide the patholo-
gist in interpreting the findings.
3.1 Light microscopy
The fixative for LM is buffered 10% aqueous formaldehyde solution. The 
tissue is examined using a light microscope which employs focused visible light to 
magnify objects viewed. Stains are used to enhance characterization of the tissue; 
common stains are H&E, periodic acid-Schiff (PAS), Silver, and Trichrome. Light 
microscopy (LM) shows predominantly proliferative lesions, and occasionally 
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membranous features and crescents. It gives limited magnification and so there is 
often a need for EM and or IHC to avoid missed diagnosis.
3.2 Immunohistochemistry
This includes immunofluorescence (IF) and immunoperoxidase (IP). The 
choice of which to use often depends on the pathologist and resources available. 
Immunoperoxidase (IP) requires no special fixation, since a tissue pre-fixed in 
formalin for LM can be used for IP depending on the question to be answered. 
It produces well-developed antigen retrieval and results are reproducible [14]. 
Immunofluorescence is the choice of most renal pathologist. The fixation used is 
Zeus solution (modified Michel’s tissue fixative). IF produces accurate location 
of deposits with the aid of dark field microscopes, and excellent resolution when 
fluorescence microscopes with epifluorescence attachments are used. Routine 
examinations during IF include immunoglobulin’s (IgG, IgM, IgA), complements 
(C3, C1q, C4) fibrin, kappa and lambda chains. Other antibodies may be examined 
depending on the question to be answered, e.g. C4d in allograft biopsies.
3.3 Electron microscopy
The fixative for EM is 2–3% glutaraldehyde or 1–4% paraformaldehyde. Electron 
microscopy (EM) aids in visualizing the ultrastructure and cross section of the 
kidney tissue including the glomerular basement membrane, mesangium, capillary 
loops, tubulointerstitium, vessels. Immune deposits are also well visualized.
Ideally all three histopathologic examinations discussed above should be per-
formed on all individual patient’s specimens received to avoid missed diagnosis. 
Diagnosis such as light chain-associated disease, IgA nephropathy, anti-glomerular 
basement membrane disease may be missed without IHC, while diagnosis such 
as minimal change disease, fibrillary glomerulopathy, immunotactoid glomeru-
lopathy, dense deposit disease, Alports, and thin glomerular basement membrane 
nephropathy may be missed without an EM.
4. Appraisal of the methods
The image guided percutaneous techniques are successful in terms of tissue yield 
in majority of cases. Furthermore, image guidance is particularly instrumental to 
the safe performance of focus biopsies in cases of cystic kidneys and solid renal 
masses [9]. Apart from methods described earlier, newer imaging techniques, such 
as, CT fluoroscopy and fusion ultrasonography may apply to renal biopsy in the 
future [15].
Percutaneous ultrasound guided approach is standard care for biopsy of non-
focal lesions [7]. The real-time ultrasound guided technique has been compared to 
the blind technique after localisation with ultrasound, and no significant difference 
in tissue yield was noted [16]. Both techniques have similar potential complications 
and can be used in similar patients. The rates of complications associated with PRB 
are difficult to compare across studies because of the heterogeneity of studies in 
terms of technique and needle used, operator and definitions of complications, 
e.g. bleeding [7]. These procedures are however done routinely without need for 
overnight admission except severe complications arise.
Tissue diagnosis may not be successful in about 6% of ultrasound guided 
biopsies in some series and common reasons are due to operator’s technique, type/
size of biopsy needle, and patient factors (reduced GFR, small atrophic kidneys, 
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anatomically complex kidneys). Some comparative studies have reported that 
automated needles provide superior yield and lower major complication rates than 
older, hand-driven (Tru-Cut) systems [17, 18]. A 14- or 16-gauge needle provides 
larger cores and the tissue yields are comparable however, the 14-gauge needle is 
reportedly associated with more bleeding complications [19, 20]. The 18-gauge 
needle on the other hand is smaller and some studies report a lower tissue yield [19, 
20]. A study by Kriegshauser et al. found that operator experience, taking multiple 
specimens, and using the cortical tangential approach significantly improved the 
pathologic material obtained during native renal biopsies [21]. It also helps to have 
a light microscope available during renal biopsy procedure, to visualize biopsy core 
immediately after it is obtained.
The CT-guided method can be used in obese patients and other patients who are 
unable to lay prone, patients with complex anatomy, and when the kidneys are not 
sufficiently visualised by ultrasound scan [8]. This procedure has been associated 
with 100% success in some reports [22]. Biopsy of focal lesions is more successful 
with CT-guidance using either core biopsy or aspiration needle, although some 
authors have reported increased diagnostic yield when a combination of both 
needles are used [9]. Unlike the ultrasound-guided technique, it is not performed 
real-time and patients are exposed to some radiation. Most patients will usually 
require conscious sedation but can be discharged a few hours after the procedure 
provided there are no major complications.
Contraindications to PRB such as uncontrolled severe hypertension, morbid 
obesity, uncontrolled bleeding diathesis, solitary kidney, small kidneys, complex 
kidney anatomy (e.g. high location, horse-shoe kidney), and renal impairment; are 
often reasons for selection of alternative techniques. Additionally, failed percutane-
ous biopsy, poor visualization on imaging, cystic kidney with rapidly progressing 
GN, and high location of the kidneys are some indications for a laparoscopic or 
open biopsy [13]. The major advantages of the laparoscopic and open biopsy 
techniques are the opportunity for direct visualization of the kidney and good 
intra-operative haemostatic control of the biopsy site [13]. The tissue yield is often 
abundant and diagnostically useful, however the risks of general surgery/anaesthe-
sia, need for special surgical skill, overnight admissions and high costs are some of 
the disadvantages.
The transjugular technique is most popular for combined liver and kidney 
biopsy, and in patients with certain contraindications to PRB (bleeding, inability to 
lie prone due to obesity, ascites or respiratory difficulty) in whom pathological diag-
nosis might alter clinical management. Diagnostic yield is comparable with PRB, 
but differs slightly depending on the approach used, 73–95% diagnostic yield has 
been reported for the aspiration needle approach [23–26] compared with 89–96.5% 
for the core biopsy needle [27, 28]. Although judged to be a safe and efficient pro-
cedure, there is the risk of contrast induced nephropathy and capsular perforation, 
which might require coil embolisation. Major complications are seen in 1–18% of 
cases when using the aspiration needle [23–26], compared to 2.7–27% with the core 
biopsy technique [27, 28]. Rathod et al. in India reported capsular perforation in five 
out of nine patients who had TRJRB using the core biopsy approach, although none 
had major event requiring intervention (blood transfusion or embolisation) [11]. 
Contrast nephropathy is a concern given that a significant proportion of patients 
undergoing this procedure have baseline renal impairment, but only 15–30 ml 
of contrast is used. There is usually no need for overnight stay as patient can be 
discharged as early as 4 hours post procedure.
Finally, regardless of the renal biopsy method selected, the nephrologist must 
ensure adequate pre- and post-care of the patient and obtain informed consent. 
Biopsy protocols should ideally exist in every centre carrying out renal biopsies, 
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and should be strictly adhered to. It is standard practice before kidney biopsies to 
check patient’s vital signs, obtain a complete blood count, international normalized 
ratio/prothrombin time, activated partial thromboplastin time, serum creatinine, 
urine culture, and group/crossmatch blood. Medications should be reviewed for 
drugs that may increase bleeding risk. Intravenous access is needed and anxious, 
uncooperative, and/or pediatric patients may require conscious sedation or general 
anesthesia. Biopsy tissue histology must only be interpreted by experienced and 
competent pathologists.
5. Conclusion
Renal biopsy can be an indispensable tool in the diagnosis, monitoring, treat-
ment, and prognosis, of patients with non-focal or focal renal parenchymal disease 
or systemic diseases with renal manifestation. The diagnostic usefulness signifi-
cantly depends upon the operator’s ability to select and prepare the patient based 
on in depth knowledge of the indications, contraindications and complications. 
The operator’s skill, choice of technique and instruments are key factors that will 
determine the safety and efficacy of the procedure.
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